Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 100

253.80p
   
  • Change Today:
      0.80p
  • 52 Week High: 293.40p
  • 52 Week Low: 196.20p
  • Currency: UK Pounds
  • Shares Issued: 2,049.79m
  • Volume: 7,218,029
  • Market Cap: £5,202m
  • RiskGrade: 96

ConvaTec expands insulin manufacturing partnership with Medtronic

By Maryam Cockar

Date: Thursday 30 Mar 2017

LONDON (ShareCast) - (ShareCast News) - Medical technology company ConvaTec has expanded its insulin pump manufacturing partnership with Irish medical device company Medtronic to meet growing demand.
The FTSE 100 company's subsidiary, Unomedical, has strengthened its capabilities to produce a range of infusion sets and insulin pump therapy solutions offered by Medtronic's Diabetes Group.

This new expanded partnership builds on their existing collaboration as the companies have working together on diabetes and insulin pump therapy since 1997.

The company claims there is increasing demand for insulin pump therapy from people with diabetes, as about 700,000 people worldwide, mostly with type one diabetes, use the therapy, according to Daedal Research in March 2016.

Unomedical develops and supplies a range of disposable infusion sets, a component of an insulin pump, to Medtronic including MiniMed QuickSet, MiniMed Silhouette, MiniMed Sure-T and MiniMed Mio.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 253.80p
Change Today 0.80p
% Change 0.32 %
52 Week High 293.40p
52 Week Low 196.20p
Volume 7,218,029
Shares Issued 2,049.79m
Market Cap £5,202m
RiskGrade 96

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.58% below the market average96.58% below the market average96.58% below the market average96.58% below the market average96.58% below the market average
87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average
Price Trend
65.04% above the market average65.04% above the market average65.04% above the market average65.04% above the market average65.04% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average
Income
78.81% below the market average78.81% below the market average78.81% below the market average78.81% below the market average78.81% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Growth
31.71% below the market average31.71% below the market average31.71% below the market average31.71% below the market average31.71% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

What The Brokers Say

Strong Buy 6
Buy 8
Neutral 4
Sell 1
Strong Sell 0
Total 19
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-24 17-Aug-23
Paid 23-May-24 28-Sep-23
Amount 4.46¢ 1.77¢

Trades for 14-Jun-2024

Time Volume / Share Price
16:37 94,620 @ 253.68p
16:35 329,997 @ 253.80p
16:35 5,459 @ 253.80p
16:35 3,686,223 @ 253.80p
16:35 9,447 @ 253.80p

CTEC Key Personnel

CEO Karim Bitar
Chair John McAdam
CFO Jonny Mason

Top of Page